About Us

The Genesis Of An Idea.

The Analytic for Hemodynamic Instability (AHI) and ultimately Fifth Eye originated from the idea that clinicians needed a better early warning indicator of an oncoming patient crash using existing physiologic information. The goal was to provide doctors and nurses an intuitive heads-up so they could take action to save the patient’s life.

The Beginning.

In 2014 a team of physicians, nurses, data scientists and computer scientists began exploring a data set developed by the U.S. Army that simulated hypovolemia (hemorrhage) on healthy volunteers. Using sophisticated machine learning techniques, the team looked at a variety of patient data streams and ultimately settled on using a single real-time stream of rich, information-dense ECG data to develop a proof of concept analytic that outperformed traditional vital signs in predicting patient deterioration.

From Academic Hospital To The World.

In 2018, Fifth Eye licensed the technology from the University of Michigan in order to transform it into an easy to use and powerful tool for clinicians around the world. The Fifth Eye team has completed product development, received U.S. FDA grant of De Novo classification, and is now working with early adopting partners who are interested in being at the forefront of healthcare improvements.

Our Team

JEN BAIRD

CEO, BOARD MEMBER

Successful venture-backed serial entrepreneur

JEFF BASCH

CFO

Broad cross-functional management expertise across multiple startups

MARK SALAMANGO

CTO, BOARD MEMBER

25+ years leading software product development teams

ASHWIN BELLE, PHD

CHIEF ANALYTICS OFFICER

Expert data scientist with specialization in signal processing, computational medicine, and machine learning

BRYCE BENSON, PHD

DATA SCIENTIST

Expert in bioengineering, cardiac electrophysiology, signal processing, biomedical data analysis

Tom Shehab

TOM SHEHAB, MD

BOARD MEMBER

Over 25 years of diverse healthcare experience as a physician, healthcare executive, and successful venture capitalist

BILL SCHMIDT

BOARD MEMBER

25+ years experience in medical device and health IT sectors, including successfully building and exiting a digital health company and serving as Managing Director of Cultivation Capital’s Life Sciences Fund.

AELIN

CHIEF CANINE OFFICER

Friend to all. Lover of a power nap.

Our Partners

AHI Is The New Standard For Detecting Hemodynamic Instability. Contact Us To Learn More.

All I can say is wow! That is awesome.

Nurse Trainer

Yes, this is a game-changer. The industry absolutely needs a better detection system for hemodynamic instability.

Chief Medical Officer

This is an amazing breakthrough! I can see so many applications within the hospital. I would like to get you connected to our innovation center so that we could be involved in its development.

Chair, Vascular Surgery

The linkage of an early response team with this technology would have a very high likelihood of being associated with a significant survival benefit.

Chief Medical Officer

We have a couple of teams dabbling in "early warning" models but they have not distilled it down to a single ECG lead!

Chief Medical Officer

The key value proposition is in accurately predicting problems before they happen to aid in the recognition and rescue of the deteriorating patient…this makes it a novel next generation monitoring and predicting tool.

Critical care/ED MD